Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs enoxaparin after total gastrectomy in gastric cancer
IRCT20220530055031N6Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in gastric cancer (GC) comparing Apixaban with Enoxaparin (2 arms). Started Sep 2024; status: completed.
02
Drugs
apixabanenoxaparin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on IRCT20220530055031N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220530055031N6.